Methylprednisolone Sodium Succinate 125mg Vial from Japan
Injectable lyophilized powder vial of 125mg methylprednisolone sodium succinate for IV/IM administration in acute conditions like anaphylaxis. HTS 3004.32.00.40 applies as it's a measured dose product containing methylprednisolone salts for therapeutic use.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Include sterility testing certificates and endotoxin reports; FDA requires them for injectables
• Declare as 'sterile pharmaceutical' to trigger proper biologics review pathway